A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge Study
Clinical trial NCT02588521 · COMPLETED
Trial details
- NCT number
- NCT02588521
- Sponsor
- Alios Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-31
- Primary completion
- 2017-08-14
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.